Health

In a first, medicine to treat Alzheimer’s fully approved in US

The US Food and Drug Administration on Thursday granted full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the brain-wasting disease that leads to a gradual decline in memory, thinking and behaviour.

Trial data showed that the treatment slows progression of the brain-wasting disease by 27% for patients in the earliest stages of Alzheimer’s.

The Centers for Medicare and Medicaid Services said Thursday that it will now expand coverage of the drug, broadening access for up to an estimated million people with early forms of the disease, according to a CNN report.

The drug was approved only for people with early forms of Alzheimer’s disease, those with mild cognitive impairment or mild dementia who have been confirmed to have amyloid plaques in their brains. Dr. Lawrence Honig, a professor of neurology at Columbia University Irving Medical Center, estimates that group constitutes about a sixth of the more than 6 million Americans currently diagnosed with Alzheimer’s, CNN reported.

People with more advanced forms of the disease may not benefit from the drug, he said, and may face increased safety risks.

Japanese drugmaker Eisai received conditional approval from the FDA in January based on early results suggesting Leqembi worked by clearing a sticky brain plaque linked to the disease.

FDA confirmed those results by reviewing data from a larger, 1,800-patient study in which the drug slowed memory and thinking decline by about five months in those who got the treatment, compared to those who got a dummy drug.

Leqembi is priced at about $26,500 for a year’s supply of IVs every two weeks.

Eisai has told investors that about 100,000 Americans could be diagnosed and eligible to receive Leqembi by 2026. The drug is co-marketed with Cambridge, Massachusetts-based Biogen.

IN Bureau

Recent Posts

Foreign Secy reaffirms deepening of India-Mauritius ties during visit to the nation

Foreign Secretary, Vikram Misri, paid his first official visit to Mauritius on December 20-22. The…

2 minutes ago

PM Modi meets President of Kuwait Heritage Society, praises works of preserving India-Kuwaiti artefacts

PM Modi meets President of Kuwait Heritage Society, praises works of preserving India-Kuwaiti artefacts Official…

9 minutes ago

EAM Jaishankar honoured with Sri Chandrasekarendra Saraswathi National Eminence Award for public leadership

External Affairs Minister S Jaishankar was awarded the Sri Chandrasekarendra Saraswathi National Eminence Award for…

19 hours ago

PM Modi interacts with Indian workers at Gulf Spic Labour Camp in Kuwait

Prime Minister Narendra Modi on Saturday visited the Gulf Spic Labour Camp in Kuwait, where…

19 hours ago

INS Tushil makes first port call to London on maiden deployment

INS Tushil made its first port call to London as a part of its maiden…

19 hours ago

Kuwait: PM Modi receives grand welcome from Indian diaspora; watches cultural performance, meets 101-year-old ex-IFS officer

Prime Minister Narendra Modi, arrived in Kuwait with a rousing welcome, as members of the…

2 days ago